Immucor (BLUD) +3.9% to $20.76 as RBC Capital Markets upgrades the company to 'outperform' from...


Immucor (BLUD) +3.9% to $20.76 as RBC Capital Markets upgrades the company to 'outperform' from 'sector perform' and increases the 12-month price target to $25 from $19. Immucor makes products used to screen donated blood.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs